eChapters

2.1. Classification of Fish

Fish are incredibly diverse aquatic vertebrates. There are over 32,000 de scribed species of bony fish, over 1,100 species of cartilaginous fish, and over 100 hagfish and lampreys. Fish can be broadly classified into three groups:

2.1.1. Superclass Agnatha (Jawless fish): These are the most primitive fish, lacking jaws and paired fins. They have existed for over 500 million years. Examples include lampreys and hagfish.

2.1.2. Class Chondrichthyes (Cartilaginous fish): These fish have skeletons made of cartilage instead of bone. They have jaws and paired fins. Examples include sharks, skates, and rays.

2.1.3. Superclass Osteichthyes (Bony fish): This is the largest and most diverse group of fish. They have skeletons made of bone and have jaws and paired fins. Examples include tuna, salmon, goldfish, and many more.

The world turned into a grossly inhabitable during the infamous COVID-19 pandemic, with community health issues everywhere. Each one felt unsafe if other earthly inhabitants were, be it humans or other living beings. Onset of SARS CoV-2 set a ‘new normal’ world order. The ever-evolving and mutating SARS CoV-2 variants extended the pandemic wave after wave thereby complicating the situation, pushing the global healthcare system to its limits and exposing its underbelly. The continually evolving variants were more aggressively transmissive and infective. As the world still reels under tremendous healthcare pressure, other infectious diseases are emerging as are identified by the World Health Organisation (WHO), creating international health emergency situations. The situation becomes alarming with the increasing zoonotic (spillover) and reverse zoonotic (spillback) factors being more proactive in the disease spread. There is a greater need to vaccinate not only humans but also animals, especially the domesticated ones and known reservoirs/carriers. Vaccines must be developed on priority and equitably distributed as the first step to counter a pandemic or potential pandemic. Vaccination is self-limiting due to increasing reported breakthrough infection cases. A strong link of the environmental health to the overall global health needs to be acknowledged, and due diligent measures taken. Hence, there is a strong need of the One Health approach as a 360° solution, and follow it up at global-scale both in letter and spirit. This chapter discusses spillover and spillback of diseases like SARS-CoV-2 and Mpox as case examples, the mitigation strategies and the need for workable One Health models, and challenges and measures to counter future outbreaks. It stresses on foolproof vaccination strategies across to catalyse individual and herd immunities for universal wellbeing.

1    General post mortem examination and detection of date and time of death

2    Pathogenomonic lesions of different diseases

3    Livestock insurance

4    Pet-dog insurance

Introduction 
Before 1800, it was believed that organic compounds could only be synthesized by living organisms, not possible in the laboratory. Friedrich Wohler successfully synthesized the first organic compound urea in the laboratory. Recently, synthetic organic chemistry has been a well-established science to construct derivative or new compounds, which have been utilized in the fields of medicine, food, clothing, nutrition, polymers, plastic, highly durable materials, and high energy fuels, that are beneficial to humans, and society. To achieve faster organic transformations, many advancements have been made, as a result, catalysts have been taken into account, which provides an alternate faster path for the reaction by lowering the activation energy. The catalysts play a very crucial role in achieving organic transformations more efficiently, affordably, and with higher yields in less time. Additionally, the catalyst which is environment-friendly and easily recoverable after completion of the process, would be beneficial in both economic and ecological ways (Trost, 1991). The utilization of nanoparticles as catalysts in organic transformations is more advantageous over conventional catalysts because of lower catalyst loadings, and high performance of the reaction in heterogenous phase. The large surface area of nanoparticles is responsible for high reactivity towards organic transformations. Till now, many nano-dimension metals like gold (Au), silver (Ag), platinum (Pt), and palladium (Pd) efficiently utilized to catalyze organic transformations (Muskan et al., 2022). The ever-growing demand for productive and sustainable catalytic systems has driven the utilization of transition metal nanoparticles as catalysts in organic conversions (Pathak et al., 2024). Among these, copper-based nanoparticles have shown great potential as catalysts due to their large surface area and variable oxidation states, which enable them to function as both oxidizing and reducing agents, effectively replacing traditional palladium catalysts (Pathak et al., 2024). Copper-based nanoparticles having specific physicochemical properties, varying in size, porosity, surface/volume ratio, and shape can also be synthesized through different physical, chemical, and biogenic methodologies. Most physical and chemical methods are considered toxic, have huge energy demands, and have high-temperature demands. In contrast, biogenic methods are simple and non-toxic. The biogenic procedure can be done by using microbes, fungi, algae, plants, extracts, etc. This chapter provides insights into various aspects of the biogenic synthesis of copper-based nanoparticles using plants and multiple catalytic applications in recent organic transformations.

Q1. The exit of drug from C.S.F. irrespective of its entry is by

1. Passive diffusion
2. Filtration
3. Facilitated diffusion
4. All of the above

Q2. The number of half-lives required to reach 99% of steady state concentration is

1. 3.3
2. 4.4
3. 5.5
4. 6.6

Q3. The receptor concept was first introduced by

1. J.N. Langley in 1878
2. Simonis in 1964
3. Paul Ehrlich in 1926
4. Walksman in 1826

1. Introduction:- Understanding Good Laboratory Practices (GLP)
1.1 Definition and Core Principles of GLP
The Organisation for Economic Co-operation and Development (OECD) defines Good Laboratory Practice as “a managerial quality control system that governs the organizational process and the conditions under which non-clinical health and thus, environmental safety studies are well planned, executed/ performed, vigilantly monitored, properly recorded, reported, and finally archived”. This definition highlights that Good Laboratory Practices (GLP) is a comprehensive framework focused on ensuring the quality and integrity of the entire study lifecycle, rather than dictating the scientific validity of the research itself. The primary goal of GLP is to ensure process integrity and data traceability, which are essential for the regulatory acceptance of safety data for a variety of products. These products include pharmaceuticals, pesticides, cosmetics, veterinary drugs, food additives, feed additives, and industrial chemicals, all of which undergo non-clinical testing to assess their potential health and environmental risks. It is important to note that GLP principles specifically apply to these non-clinical studies and exclude research involving human subjects. The OECD Principles of GLP are internationally recognized and serve as the basis for GLP regulations in numerous countries worldwide. These principles outline the responsibilities of key personnel involved in non-clinical studies, including test facility management, the study director, study personnel, and quality assurance personnel. Furthermore, they establish minimum standards concerning the suitability of facilities and equipment to perform studies, as well as the necessity for comprehensive Standard Operating Procedures (SOPs) to guide all aspects of laboratory operations. The core principles of GLP encompass a wide range of elements critical to ensuring the quality and integrity of laboratory studies. These OECD principles of Good Laboratory Practices (GLP) include: the proper organization team and personnel staff members within the testing facility, the well establishment of a robust quality assurance programme, the better suitability and proper maintenance of various necessary facilities, the efficient management of apparatus, materials, and reagents, the characterization and control of test systems, the handling of test and reference items, the development and adherence to Standard Operating

During recent years ultrasonography has become an indispensable diagnostic modality in human and veterinary medicine because of its non-invasive nature, providing visualization of internal organs, and quick results. Birth of ultrasound took place in 1794 when an Italian biologist Lazzaro Spallanzani discovered that bats used sound waves for navigation. Since then continuous developments and advancements in the technology have made the sonography a dependable and an easily accessible diagnostic modality.

Ultrasonography is being routinely practiced in canine and feline medicine for the diagnosis of diseases of the organs and also to confirm pregnancy. Its routine use in ruminant medicine is mainly restricted to pregnancy diagnosis. Recently the potential of ultrasonography is also being explored in zoo and wild animals as well as in exotic pets. Information available in companion and other domestic animals cannot be applied blindly to zoo and wild animals.

Despite its existence and continued use over many centuries, and its popularity and extensive use during the last decade, traditional medicine has not been officially recognized in most countries. Consequently, education, training and research in this area have not been accorded due attention and support. The quantity and quality of the safety and efficacy data on traditional medicine are far from sufficient to meet the criteria needed to support its use worldwide. The reasons for the lack of research data are due to not only to health care policies, but also to a lack of adequate or accepted research methodology for evaluating traditional medicine235.

The statement from General Guidelines for Methodologies on Research and Evaluation of Traditional Medicines (World Health Organization, 2000) highlights the need for consensuous in addressing the problems related to the quality of botanical drugs, which ultimately is a critical determinant of safety and efficacy of medicine. Further, the distribution and widespread sale of adulterated, misbranded, spurious botanical drug products and marked increase in misleading health claims of these products demands proper regulations on botanical medicine to protect public health236. Considering these two issues development of parameters for quality control standardization and regulatory norms for controlling the growing business of botanicals is a big task. Various regulatory authorities, research organizations and botanical drug manufacturers are constantly contributing to developing guiding principles addressing issues related to quality, safety and efficacy237. In this chapter we have highlighted problems associated with quality control of the botanicals and tried to guide a way towards a globally acceptable quality standard.

Introduction 

A toxin (Greek: ôïîéêüí, toxikon, lit. (poison) for use on arrows) is a poisonous substance produced by living cells or organisms that is active at very low concentrations. Toxins can be small molecules, peptides, or proteins and are capable of causing disease on contact or absorption with body tissues by interacting with biological macromolecules such as enzymes or cellular receptors. Toxins vary greatly in their severity, ranging from usually minor and acute (as in a bee sting) to almost immediately deadly (as in botulinum toxin)

A toxin is simply a poison that can affect the body by internal or external means. A toxin can be a chemical which occurs naturally or in synthetic form. More than 120,000 human-made chemicals have been introduced into the environment, in one form or another, and this number continues to grow each year at a phenomenal rate. At the same time, microbial toxins, being influenced by the vast numbers of chemicals, are mutating beyond belief.

Pollution is the introduction of contaminants into an environment that causes instability, disorder, harm or discomfort to the physical systems or living organisms they are in.  
Pollution can take the form of chemical substances, or energy, such as noise, heat, or light energy.

Pollutants, the elements of pollution, can be foreign substances or energies, or naturally occurring; when naturally occurring, they are considered contaminants when they exceed natural levels. Sometimes the term pollution is extended to include any substance when it occurs at such unnaturally high concentration within a system that it endangers the stability of that system. For example, water is innocuous and essential for life, and yet at very high concentration, it could be considered a pollutant.

Genetic improvement creates permanent, heritable gains in milk production, growth, fertility, disease resistance and environmental adaptation. This chapter explains how artificial intelligence complements conventional phenotypic and pedigree-based selection by analysing large genomic and performance datasets. Machine-learning models reveal genotype-phenotype relationships, predict breeding values and support earlier, more reliable selection. Applications include genomic selection, precision breeding, reproductive technologies, bioinformatics and digital twins. AI can reduce generation intervals and improve the efficiency of breeding programmes, but its success depends on data quality, representative populations and interpretable models. Ethical concerns, genetic diversity and long-term sustainability must also be considered when designing AI-supported breeding systems.

Genetic improvement creates permanent, heritable gains in milk production, growth, fertility, disease resistance and environmental adaptation. This chapter explains how artificial intelligence complements conventional phenotypic and pedigree-based selection by analysing large genomic and performance datasets. Machine-learning models reveal genotype-phenotype relationships, predict breeding values and support earlier, more reliable selection. Applications include genomic selection, precision breeding, reproductive technologies, bioinformatics and digital twins. AI can reduce generation intervals and improve the efficiency of breeding programmes, but its success depends on data quality, representative populations and interpretable models. Ethical concerns, genetic diversity and long-term sustainability must also be considered when designing AI-supported breeding systems.

Introduction

The word mycotoxin is derived from myco, meaning mold and toxin, a poison. A great number of mold metabolites have been identified as mycotoxins. Thus mycotoxins are secondary fungal metabolites (i.e., metabolites not essential to the normal growth and reproduction of the fungus) which cause pathologic, physiologic, and/or biochemical lesions in other species (may include animals, plants, other microbes, etc.).

Respiratory tract disorders in domestic animals
The respiratory system is vital for efficient oxygen exchange, metabolic function, and overall health. Respiratory tract disorders in livestock speciesare among the most significant health challenges, leading to  economic losses in terms of reduced productivity, treatment costs, and mortality. Thesedisorders can affect the upper respiratory tract (URT), lower respiratory tract  (LRT), or both. Overview of common respiratory diseases in livestock, their aetiology, clinical manifestations, pathophysiology, diagnostic approaches, and management strategies are summarized as follows: -
1. Bovine Respiratory Disease Complex (BRDC)
? Species affected: Cattle
? Etiology: Multifactorial; involves viruses (Bovine herpesvirus-1, Bovine respiratory syncytial virus, Parainfluenza-3, Bovine viral diarrhea virus), bacteria (Mannheimia haemolytica, Pasteurella multocida, Mycoplasma bovis), and environmental stressors

Drugs acting on alimentary system

Drugs acting on respiratory system

Drugs acting on urinary system

Drugs acting on genital system

Drugs acting on musculoskeletal system

Antineoplastic drugs

Antimicrobials

Antifungal

Antiprotozoal

Anthelmintics

1.1. Introduction

Wildlife management often requires interventions to safely handle and transport animals. Chemical restraint, also known as immobilization or tranquilization, is a technique widely used to facilitate these processes (Hernandez, 2014). It involves the administration of drugs to temporarily immobilize wild animals, allowing for various procedures such as veterinary medical examinations, tagging, relocation, or rehabilitation. This chapter provides an overview of the principles, methods, drugs, and considerations involved in the chemical restraint of wild animals.

It has been often stated that the most important techniques required by the zoo veterinarian are those used in the capture and restraint of the patient. These techniques have developed into a highly technical science (Clarke et al., 2014). In the early days of zoos, the only practical method was to manually catch and hold the patient. Modern techniques, however, permit a veterinarian to shoot a CO2 powered gun, which discharges a projectile syringe at an animal resulting in complete immobilization of the animal (Jacques et al., 2009). This is accomplished without any physical contact between the patient and his captors.

Genetics forms the basis of human life. All individuals have a physical and physiological self, determined by the interactions of genes and environment. Pharmacogenetics is the connotation used to study how heritability affects an individual’s response to drugs.494 The term ‘Pharmacogenomics’ represents systematic identification of all human genes, their products, interindividual variation and intraindividual variation in expression and function over time. It focuses on candidate genes and may include transcriptome and proteome information that affect drug metabolism, pharmacokinetics, and pharmacodynamics. It helps in predicting the patient’s response to a drug and to design new drugs495. Pharmacogenetics is study of single genes and the effects on drug response while pharmacogenomics is related to overall variation in genome. A gene is considered polymorphic when a mutation appears in more than 1% population, which may be present in the form of single nucleotide polymorphism (SNP), simple sequence length polymorphism (SSLP) and nucleotide addition or deletion. After the Human Genome Project, study in this field is accelerated dramatically. It was found that out of 1.4 million SNPs identified in the human genome, over 60,000 are present in the coding region496. These SNPs lead to miscoding of the various proteins that plays crucial role in the biological processes. If a point mutation is present in the gene coding region for various drug-metabolizing enzymes, drug target and drug transporters, it can lead to many non-therapeutic and unpredictable drug responses. In United States, over two million people suffer from severe adverse drug reactions per year and about 100,000 cases are life threatening497.

Animal husbandry faces increasing pressure to produce safe milk, meat and eggs while improving animal welfare and reducing environmental impacts. Traditional observation-based management is increasingly inadequate for large and complex livestock systems. This chapter introduces digital transformation through Precision Livestock Farming, which combines IoT devices, smart sensors, wearables, computer vision, artificial intelligence, machine learning and digital twins. Continuous animal-centred data enables timely decisions concerning health, reproduction, feeding, behaviour and welfare. The chapter explains how digital technologies can support early disease detection, efficient resource use and improved productivity across commercial and smallholder farms, creating more profitable, sustainable and welfare-conscious livestock systems.

Recent pandemic (COVID-19) impacted global economy significantly and increased economic disparity. Vaccines are significantly beneficial and cost effective compared to other public healthcare preventives. Vaccines reduce hospitalisation, treatment costs and associated morbidity and mortality. Although COVID-19 vaccination and natural viral infection protected against reinfection, it waned in part due to emerging novel variants. Waning immunity from vaccine and natural infection are documented, and it was more so in severe hospitalised COVID-19. Many countries developed their own vaccines successfully to counter as COVID-19 became global. Vaccines needed updates to effectively fight COVID-19 as the wild strain constantly mutated. Among the intrinsic, perinatal, extrinsic, environmental, behavioural and nutritional aspects, the host factors included antibiotics usage pattern, sleep habits, physical activities, smoking habit and alcohol intake. Similarly, the external factors influencing vaccine response included childhood vaccination, early-age infections, nutrient supplements soon after birth, and breastfeeding pattern. Vaccination time also affected the efficacy. Forenoon vaccination developed less breakthrough infection compared to afternoon or evening vaccination due to varying immunological responses like immune cell functions, recruitment and transport, owing to circadian rhythm. Although vaccination side-effects are there, almost all vaccines are reportedly safe, effective and prevented serious illness, hospitalisation and death. Vaccine usually takes two weeks to manifest, and it prevented 14·4–19.8 million pandemic fatalities globally in 185 nations in a single year during December 2020 and December 2021. It was necessary that the boosters alongside vaccines enhanced immunological effects and provided extended protection. Thus, vaccine and booster design and development, dosing, targeted immunisation, cost-efficacy and vaccine acceptance are challenges to address. Government, not-for-profit organisations, health agencies and researchers may systematically analyse, justify and validate vaccine R&D and vaccinations economics. This chapter comprehends biological, commercial and economic benefits and impacts of booster dose in vaccination drives, and the roadmap ahead.